Woodcock: COVID-19 Pandemic Is Not The Time For Structural Changes At US FDA
Source : 'HBW Insight'
Acting US Food and Drug Administration Commissioner Janet Woodcock cautioned against implementing disruptive changes at the agency now due to the ongoing COVID-19 pandemic that continues to leave the agency's...
Developer Of First US OTC COVID-19 Antigen Test Plans 'Digital Diagnostics For Multitude Of Infectious Diseases'
Source : 'HBW Insight'
Earlier this year the Biden administration made a big bet on small Australian test maker Ellume Ltd. by giving it $231m to build a plant in the US to mass...
Germany's OTC Market Struggling To Recover To Pre-Pandemic Levels
Source : 'HBW Insight'
As Germany battles a third wave of coronavirus infection, sales of OTC medicines through the country’s bricks-and-mortar and online pharmacies are lagging behind previous years, according to a recent report...
Estee Lauder Companies Sees Regional Signs Of ‘Makeup Renaissance’
Source : 'HBW Insight'
The Estee Lauder Companies, Inc. continues to bet heavily on skin care, sales of which increased 31% in reported terms to roughly $2.26bn in the fiscal 2021 third quarter ended...
Would An Independent Analysis Of US FDA's Pandemic Response Find Transformative Effect?
Source : 'HBW Insight'
A former US Food and Drug Administration commissioner, Andrew von Eschenbach, suggests an external group may offer the best chance for the agency to determine the best lessons learned by lessons...